Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug tested to boost platelets in chronic blood disorder

NCT ID NCT05369208

Completed Disease control Sponsor: Sobi, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether a drug called avatrombopag is safe and effective at raising platelet counts in Japanese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. Participants took the drug for 26 weeks, and researchers measured how often their platelet counts reached a safer level. The goal was to see if this drug could help control the disease over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sobi Site 101

    Shiwa-gun, Iwata, 028-3695, Japan

  • Sobi Site 102

    Chuo-shi, Yamanashi, 409-3898, Japan

  • Sobi Site 103

    Bunkyō City, Toyko, 113-8603, Japan

  • Sobi Site 104

    Hachiōji-shi, Tokyo, 192-0032, Japan

  • Sobi Site 105

    Toyohashi, Aichi-ken, 441-8570, Japan

  • Sobi Site 106

    Suita, Osaka, 565-0871, Japan

  • Sobi Site 107

    Hirakata, Osaka, 573-1191, Japan

  • Sobi Site 108

    Kobe, Hyōgo, 650-0047, Japan

  • Sobi Site 109

    Hiroshima, Hiroshima, 730-0052, Japan

  • Sobi Site 110

    Tōon, Ehime, 791-0295, Japan

  • Sobi Site 111

    Fujisawa, Kanagawa, 251-8550, Japan

  • Sobi Site 112

    Kofu, Yamanashi, 400-8506, Japan

  • Sobi Site 113

    Kanazawa, Ishikawa-ken, 920-8650, Japan

  • Sobi Site 114

    Gifu, Gifu, 500-8513, Japan

  • Sobi Site 115

    Fukuyama-shi, Hiroshima, 720-2121, Japan

  • Sobi Site 116

    Kitakyushu, Fukuoka, 802-8555, Japan

  • Sobi Site 117

    Kurume, Fukuoka, 830-8543, Japan

  • Sobi Site 118

    Iizuka-shi, Fukuoka, 820-8505, Japan

  • Sobi Site 119

    Kumamoto, Kumamoto, 862-8655, Japan

Conditions

Explore the condition pages connected to this study.

IMMUNE THROMBOCYTOPENIA